🇺🇸 FDA
Patent

US 11679103

Multi-targeting agents for Alzheimer's disease therapy

granted A61KA61K31/277A61K31/4439

Quick answer

US patent 11679103 (Multi-targeting agents for Alzheimer's disease therapy) held by The Regents of the University of California expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/277, A61K31/4439, A61K31/445, A61K47/54